Discover Why Health Professionals Trust NanoSALV Catalytic from NanoTess – a Novel, Cost-Effective Canadian Wound Care Technology

CALGARY, Alberta--()--Now more than ever, NanoSALV Catalytic Advanced Wound Care Treatment Matrix – the flagship technology of NanoTess is expanding their reach and helping thousands of Canadians heal their wounds and skin health concerns.

“Why should people suffer longer than they need to with an injury or a wound? We all want to heal. You know, while we’re trying to physically heal sometimes, like mentally, we might be struggling too. So just knowing that we have something that can help us decrease our healing time is huge,” says Kasey, an individual who has been living with a spinal cord injury for 24 years.

Kasey’s story and the impact of complex wounds in her community is not unique. Everyone will experience a wound in their lifetime and everyone deserves the peace of mind knowing they will heal. Unfortunately, 1 in 4 families will have a loved one who has difficulty healing or who is prone to complex wounds.

The widespread challenge of healing is referred to as the silent pandemic of complex wounds and is the focus of NanoSALV Catalytic.

NanoTess’ CEO and co-founder, Megan Leslie, is inspired every day by stories like Kasey’s. Megan states, “The entire NanoTess team is committed to our social purpose to leave no one behind. Wound care is a big problem and we will not be able to tackle it alone, so I am proud to be partnering with incredible organizations and community members to achieve this.”

Directors of Care at multiple Alberta-based long-term care centres have also seen positive impacts to their residents.

“We’re finding that our residents are much more empowered to wake up and get out of bed in the morning and go to the dining room for their breakfast, because their wound really isn’t letting them down anymore. They’re seeing those healing effects using the NanoSALV Catalytic technology.”

Beyond quality-of-life improvements, long-term care centres have also seen positive impacts on their budgets; saving in costs and resources when NanoSALV Catalytic was implemented in their care practices.

“Before we started using the NanoSALV technology, we were looking at using around $10 per  application for a simple antimicrobial dressing, we are now looking at a range of $2-$4 per treatment with the use of the NanoSALV technology. Overall, we are anticipating a significant cost reduction when we move forward in the next coming months with the continued use of NanoSALV,” a Director of Care adds.

NanoSALV Catalytic is now being adopted at a fast pace across Canada. It started with a province-wide evaluation at multiple facilities within Alberta Health Services, resulting in fast-paced adoption across Canada's largest integrated health system, responsible for delivering health services to more than 4.5 million people.

This was followed by Mohawk Medbuy Corporation, a Canadian group purchasing organization awarding an Innovation Contract to NanoTess, making NanoSALV Catalytic available to hundreds of healthcare facilities across Ontario and Canada.

Kasey emphasizes, “We all want to get back out there and be doing the things that we love and not having a wound major or minor getting in our way.”

Learn more about this novel wound care technology and its benefits for wounds and in the skin health space by visiting NanoTess’ website, nanotess.com, or contacting the Partner Success Team at support@nanotess.com.

About the Company:

NanoTess is creating new frontiers of opportunity within healthcare through catalytic innovation, beginning with skin and wound healing. With a vision to end the silent pandemic of complex wounds and improve skin health, NanoTess is on a mission to provide leading edge technology to improve patient outcomes, address the needs of both patients and healthcare providers, and reduce healthcare costs. Their flagship technology, NanoSALV Catalytic, revealed excellent results across a diverse, real-world patient population, showcasing that this technology improved wound healing by 57.6%, reduced wound care costs by ~46%, and improved mental health and quality of life for patients and their families in comparison to currently available best-in-class technologies. To date, NanoSALV Catalytic has helped thousands of Canadians heal.

References:

Contacts

Lead of Story: Riggs Vergara | riggs.zv@nanotess.com | 403-891-2033
Instagram: @nanotessinc
Facebook: https://www.facebook.com/nanotessinc
LinkedIn: https://www.linkedin.com/company/nanotess-inc
Website: https://nanotess.com

Social Media Profiles

Contacts

Lead of Story: Riggs Vergara | riggs.zv@nanotess.com | 403-891-2033
Instagram: @nanotessinc
Facebook: https://www.facebook.com/nanotessinc
LinkedIn: https://www.linkedin.com/company/nanotess-inc
Website: https://nanotess.com